By conducting in vitro cellular experiments and utilising gene editing techniques, we aim to elucidate the role of the IFIT3/TBK1 pathway in regulating the functions of pDCs and the pathogenesis of SSc. This evidence concerns the gene IFIT3 and systemic sclerosis.